Advertisement
Advertisement

PACB

PACB logo

Pacific Biosciences of California, Inc.

1.60
USD
Sponsored
+0.16
+11.11%
Jun 25, 15:59 UTC -4
Closed
exchange

After-Market

1.57

-0.03
-1.56%

PACB Earnings Reports

Positive Surprise Ratio

PACB beat 21 of 41 last estimates.

51%

Next Report

Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$41.55M
/
-$0.12
Implied change from Q1 26 (Revenue/ EPS)
+11.76%
/
--
Implied change from Q2 25 (Revenue/ EPS)
+4.49%
/
-14.29%

Pacific Biosciences of California, Inc. earnings per share and revenue

On May 07, 2026, PACB reported earnings of -0.12 USD per share (EPS) for Q1 26, beating the estimate of -0.13 USD, resulting in a 12.73% surprise. Revenue reached 37.18 million, compared to an expected 40.79 million, with a -8.85% difference. The market reacted with a -14.55% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 10 analysts forecast an EPS of -0.12 USD, with revenue projected to reach 41.55 million USD, implying an increase of 0.00% EPS, and increase of 11.76% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
NANO-X IMAGING LTD Ordinary Shares
Report Date
Jun 25, 2026 For Q1 26
Estimate
-$0.20
Actual
-$0.20
Surprise
+1.96%
FAQ
For Q1 2026, Pacific Biosciences of California, Inc. reported EPS of -$0.12, beating estimates by 12.73%, and revenue of $37.18M, -8.85% below expectations.
The stock price moved down -14.55%, changed from $1.65 before the earnings release to $1.41 the day after.
The next earning report is scheduled for Aug 03, 2026.
Based on 10 analysts, Pacific Biosciences of California, Inc. is expected to report EPS of -$0.12 and revenue of $41.55M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement